Stryker Acquires AI Blood Monitoring Company Gauss Surgical

admin

Stryker Corporation, a $14.4b medical technology company focused on orthopedics, neurotechnology and spine, acquired Gauss Surgical, a developer of artificial intelligence-enabled technology for real-time monitoring of blood loss during surgery. Gauss Surgical’s Triton system leverages a computer vision app and iPhone to measure a patient’s blood loss via imaging of sponges, towels and canisters of fluid in addition to calculating volume …

Abbott Acquires Walk Vascular

admin

Abbott Laboratories (NYSE: ABT), a $35b global producer of diagnostics, devices, generic pharmaceuticals and nutritional products, has acquired Walk Vascular, LLC, a developer of a commercialized thrombectomy system used to remove peripheral blood clots (JETi system). The JETi system works by inserting a distal catheter into veins and arteries where clots have formed.  Once the catheter is inserted, a saline …

Medtronic to Acquire Intersect ENT

admin

Medtronic plc (Nasdaq: MDT), a $30.1b Ireland-based producer of devices used in cardiovascular, neuroscience, surgical, and diabetes management applications, is acquiring Intersect ENT (Nasdaq: XENT), a developer of an ENT implant that releases steroids during sinus surgery to manage inflammation and a virtual surgical guidance platform.  In the U.S., CRS affects 1 in 8 adults (35 million) and often requires a …

The Walden Group Releases Q2 2021 Strategic Healthcare M&A Report

admin

The Walden Group is pleased to provide access to its Q2 2021 Strategic Healthcare M&A Report, which includes:     Financings (IPOs, SPACs, private) and M&A Deals are surging     Major M&A Deals by Sector     What the CEOs of Leading Medtechs are Saying     Key Stats on Top Healthcare M&A Q2 Deals     Key Stats …

TopCon Acquires Italy-based Ophthalmic Imaging Device Producer VISIA Imaging

admin

TopCon Corporation, a $1.2 billion Japan-based developer of eyecare devices and software solutions worldwide has purchased Italy-based ophthalmic device manufacturer VISIA Imaging S.r.l.  The acquisition provides Topcon with a portfolio of imaging devices focused on the anterior segment to complement its existing posterior segment imaging offerings including fundus cameras and optical coherence tomography (OCT) systems.  Topcon had distributed VISIA’s CA-800 …

Surmodics Acquires Ireland–based Vetex Medical

admin

Surmodics, Inc., a $107m maker of surface modification technologies for intravascular medical devices, has acquired Vetex Medical Ltd, an Ireland–based producer of venous clot removal products. Vetex developed ReVene, a thrombectomy catheter platform that is used to remove, in a single session, large, mixed-morphology blood clots commonly found in venous thromboembolism.  Deal value – $40m upfront with milestones up to …

Tecan Group Acquires Paramit for $1b

admin

Tecan Group Ltd, a $795m Switzerland-based global provider of laboratory instruments and solutions in life science research and clinical diagnostics, has acquired Paramit Corporation, a maker of electronics based medical devices and life science instruments. The deal accelerates Tecan’s entry into medical devices and enhances Paramit’s capabilities and market leadership in life sciences. Paramit provides fully integrated engineering, manufacturing, and …

DENTSPLY SIRONA Inc. Acquires Propel Orthodontics for $131M

admin

DENTSPLY SIRONA (Nasdaq: XRAY), a $3.3b provider of dental technologies, equipment and consumables has acquired Propel Orthodontics, developer of the VPro, a vibratory orthodontic device that seats aligners in 5 minutes a day for at-home use.  The VPro device is used with Propel’s Fastrack Mobile App that patients can use to track usage and share information with providers online.  The …

Japan-based Olympus Corporation Acquires Israel-based Medi-Tate

admin

Adds an in-office treatment for benign prostatic hyperplasia (BPH) treatment to Olympus’ leading urological devices portfolio.  Medi-Tate‘s “iTind” has received FDA de Novo authorization and a European CE mark.  Since November 2018, Olympus secured distribution rights to iTind via an initial investment.  The incidence of BPH is one of the most common diseases in aging men and the most common …

GE Healthcare Buys Molecular Imaging Agent Producer Zionexa

admin

General Electric (NYSE: GE), through its $18b healthcare business GE Healthcare, has acquired France-based Zionexa, the developer of a positron emission tomography (PET) imaging agent, Cerianna, used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions in recurrent or metastatic breast cancer care.  Cerianna was FDA-approved in mid-2020 and commercialized in December 2020.  ~168,000 people …